Synergistic Effects of Pten Loss and WNT/CTNNB1 Signaling Pathway Activation in Ovarian Granulosa Cell Tumor Development and Progression

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2008 Aug 9

PMID 18687666

Citations 55

Authors

Marie-Noelle Lague

Marilene Paquet

Heng-Yu Fan

M Johanna Kaartinen

Simon Chu

Soazik P Jamin

Richard R Behringer

Peter J Fuller

Andrew Mitchell

Monique Dore

Louis M Huneault

JoAnne S Richards

Derek Boerboom

Affiliations

Soon will be listed here.

Abstract

The mechanisms of granulosa cell tumor (GCT) development may involve the dysregulation of signaling pathways downstream of follicle-stimulating hormone, including the phosphoinosite-3 kinase (PI3K)/AKT pathway. To test this hypothesis, a genetically engineered mouse model was created to derepress the PI3K/AKT pathway in granulosa cells by conditional targeting of the PI3K antagonist gene Pten (Pten(flox/flox);Amhr2(cre/+)). The majority of Pten(flox/flox);Amhr2(cre/+) mice featured no ovarian anomalies, but occasionally ( approximately 7%) developed aggressive, anaplastic GCT with pulmonary metastases. The expression of the PI3K/AKT downstream effector FOXO1 was abrogated in Pten(flox/flox);Amhr2(cre/+) GCT, indicating a mechanism by which GCT cells may increase proliferation and evade apoptosis. To relate these findings to spontaneously occurring GCT, analyses of PTEN and phospho-AKT expression were performed on human and equine tumors. Although PTEN loss was not detected, many GCT (2/5 human, 7/17 equine) featured abnormal nuclear or perinuclear localization of phospho-AKT, suggestive of altered PI3K/AKT activity. As inappropriate activation of WNT/CTNNB1 signaling causes late-onset GCT development and cross talk between the PI3K/AKT and WNT/CTNNB1 pathways has been reported, we tested whether these pathways could synergize in GCT. Activation of both the PI3K/AKT and WNT/CTNNB1 pathways in the granulosa cells of a mouse model (Pten(flox/flox);Ctnnb1(flox(ex3)/+);Amhr2(cre/+)) resulted in the development of GCT similar to those observed in Pten(flox/flox);Amhr2(cre/+) mice, but with 100% penetrance, perinatal onset, extremely rapid growth and the ability to spread by seeding into the abdominal cavity. These data indicate a synergistic effect of dysregulated PI3K/AKT and WNT/CTNNB1 signaling in the development and progression of GCT and provide the first animal models for metastatic GCT.

Citing Articles

Complex immunohistochemical and molecular study on 5 cases of ovarian juvenile granulosa cell tumors reveals a consistent alteration in the PI3K/AKT/mTOR signaling pathway.

Safanda A, Hajkova N, Kendall Bartu M, Svajdler M, Matej R, Hausnerova J Diagn Pathol. 2025; 20(1):3.

PMID: 39773640 PMC: 11707838. DOI: 10.1186/s13000-025-01599-1.

An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers.

Nemejcova K, Safanda A, Kendall Bartu M, Michalkova R, Svajdler M, Shatokhina T Virchows Arch. 2024; 485(3):427-437.

PMID: 38904760 DOI: 10.1007/s00428-024-03854-0.

Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal.

Kulkarni S, Alampally H, Guddattu V, Rodrigues G, Carnelio S F1000Res. 2024; 11:1578.

PMID: 38895097 PMC: 11184278. DOI: 10.12688/f1000research.126091.3.

Granulosa Cells-Related MicroRNAs in Ovarian Diseases: Mechanism, Facts and Perspectives.

Xiao S, Du J, Yuan G, Luo X, Song L Reprod Sci. 2024; 31(12):3635-3650.

PMID: 38594585 DOI: 10.1007/s43032-024-01523-w.

Repopulation of autophagy-deficient stromal cells with autophagy-intact cells after repeated breeding in uterine mesenchyme-specific Atg7 knockout mice.

Oh J, Kwon S, Byun H, Song H, Lim H Clin Exp Reprod Med. 2023; 50(3):170-176.

PMID: 37643830 PMC: 10477416. DOI: 10.5653/cerm.2023.05876.

References

Mulholland D, Dedhar S, Wu H, Nelson C . PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene. 2006; 25(3):329-37. DOI: 10.1038/sj.onc.1209020. View

Kim D, Chung J . Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol. 2005; 35(1):106-15. DOI: 10.5483/bmbrep.2002.35.1.106. View

Villella J, Herrmann F, Kaul S, Lele S, Marchetti D, Natiella J . Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Pathol. 2007; 26(2):154-9. DOI: 10.1097/01.pgp.0000228143.52054.46. View

Vainio S, Heikkila M, Kispert A, Chin N, McMahon A . Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999; 397(6718):405-9. DOI: 10.1038/17068. View

Martelli A, Faenza I, Billi A, Manzoli L, Evangelisti C, Fala F . Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?. Cell Signal. 2006; 18(8):1101-7. DOI: 10.1016/j.cellsig.2006.01.011. View

Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B . Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A. 2003; 100(8):4610-5. PMC: 153603. DOI: 10.1073/pnas.0835895100. View

Wayne C, Fan H, Cheng X, Richards J . Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol. 2007; 21(8):1940-57. DOI: 10.1210/me.2007-0020. View

Naito A, Akazawa H, Takano H, Minamino T, Nagai T, Aburatani H . Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ Res. 2005; 97(2):144-51. DOI: 10.1161/01.RES.0000175241.92285.f8. View

Desbois-Mouthon C, Cadoret A, Bertrand F, Cherqui G, Perret C, Capeau J . Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene. 2001; 20(2):252-9. DOI: 10.1038/sj.onc.1204064. View

10.

Richards J . Hormonal control of gene expression in the ovary. Endocr Rev. 1994; 15(6):725-51. DOI: 10.1210/edrv-15-6-725. View

11.

Fragoso M, Latronico A, Carvalho F, Zerbini M, Marcondes J, Araujo L . Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab. 1998; 83(6):2074-8. DOI: 10.1210/jcem.83.6.4847. View

12.

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

13.

Jamieson S, Alexiadis M, Fuller P . Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors. Gynecol Oncol. 2004; 95(3):603-9. DOI: 10.1016/j.ygyno.2004.07.062. View

14.

Shen Y, Mamers P, Jobling T, Burger H, Fuller P . Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J Clin Endocrinol Metab. 1996; 81(11):4159-61. DOI: 10.1210/jcem.81.11.8923876. View

15.

Schumer S, Cannistra S . Granulosa cell tumor of the ovary. J Clin Oncol. 2003; 21(6):1180-9. DOI: 10.1200/JCO.2003.10.019. View

16.

Arden K . Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 2006; 41(8):709-17. DOI: 10.1016/j.exger.2006.05.015. View

17.

Weston C, Davis R . Signal transduction: signaling specificity- a complex affair. Science. 2001; 292(5526):2439-40. DOI: 10.1126/science.1063279. View

18.

Chodankar R, Kwang S, Sangiorgi F, Hong H, Yen H, Deng C . Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr Biol. 2005; 15(6):561-5. DOI: 10.1016/j.cub.2005.01.052. View

19.

Groszer M, Erickson R, Lesche R, Trumpp A, Zack J, Kornblum H . Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science. 2001; 294(5549):2186-9. DOI: 10.1126/science.1065518. View

20.

Ongeri E, Verderame M, Hammond J . Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathways. Mol Endocrinol. 2005; 19(7):1837-48. DOI: 10.1210/me.2004-0487. View